EUVIMEDEUVIMED entdecken
Querschnittstudie

METABOLIC EFFECTS IN PATIENTS ON SECOND GENERATION ORAL ANTI-PSYCHOTICS IN A TERTIARY CARE HOSPITAL IN CENTRAL GUJARAT: A CROSS-SECTIONAL STUDY

Vaishal D Chokshi, Vinodkumar M Darji, Divyank A Jajoo, Riddhi R Donda, Simra I Saiyed

International Journal of Academic Medicine and Pharmacy · 30.04.2025 · 7 (2) · 736-739

DOI: 10.47009/jamp.2025.7.2.148 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Academic Medicine and Pharmacy, online erschienen am 13.04.2025. Verfasst von Vaishal D Chokshi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim and objective are to assess the overall incidence of metabolic disorders among patients on second-generation oral antipsychotics. 2. To evaluate the incidence of metabolic abnormalities specific to individual SGAs. 3. To examine the correlation between socio-demographic factors and metabolic abnormalities. Materials and Methods: This prospective cohort study was conducted after Institutional Review Board (IRB) approval. Patients on risperidone, aripiprazole, olanzapine, and clozapine were enrolled through purposive sampling after informed consent. Participants were monitored for metabolic parameters, including complete blood count, total cholesterol levels, and fasting blood sugar, after three months of treatment. Data on antipsychotic type, dosage, and socio-demographic variables (age, sex, marital status, education, and residence) were collected and analyzed.

Result

The overall incidence of metabolic abnormalities among study participants was 8.547% (n=10). Olanzapine exhibited the highest prevalence of metabolic disturbances, followed by clozapine, risperidone, and aripiprazole.

Conclusion

Metabolic abnormalities associated with SGAs pose a significant health risk. Regular metabolic screening and early intervention can help improve patient quality of life.

Zitieren

APA

Chokshi, V. D., Darji, V. M., Jajoo, D. A., Donda, R. R., & Saiyed, S. I. (2025). METABOLIC EFFECTS IN PATIENTS ON SECOND GENERATION ORAL ANTI-PSYCHOTICS IN A TERTIARY CARE HOSPITAL IN CENTRAL GUJARAT: A CROSS-SECTIONAL STUDY. International Journal of Academic Medicine and Pharmacy, 7(2), 736-739. https://doi.org/10.47009/jamp.2025.7.2.148

Vancouver

Chokshi VD, Darji VM, Jajoo DA, Donda RR, Saiyed SI. METABOLIC EFFECTS IN PATIENTS ON SECOND GENERATION ORAL ANTI-PSYCHOTICS IN A TERTIARY CARE HOSPITAL IN CENTRAL GUJARAT: A CROSS-SECTIONAL STUDY. International Journal of Academic Medicine and Pharmacy. 2025;7(2):736-739. doi:10.47009/jamp.2025.7.2.148

BibTeX
@article{Chokshi2025,
  author = {Chokshi, Vaishal D and Darji, Vinodkumar M and Jajoo, Divyank A and Donda, Riddhi R and Saiyed, Simra I},
  title = {METABOLIC EFFECTS IN PATIENTS ON SECOND GENERATION ORAL ANTI-PSYCHOTICS IN A TERTIARY CARE HOSPITAL IN CENTRAL GUJARAT: A CROSS-SECTIONAL STUDY},
  journal = {International Journal of Academic Medicine and Pharmacy},
  year = {2025},
  volume = {7},
  number = {2},
  pages = {736--739},
  doi = {10.47009/jamp.2025.7.2.148}
}
Kostenlos starten →